News

ANEUVO Achieves Major Milestones with ExaStim® Success

ANEUVO Achieves Major Milestones with ExaStim® Success

ANEUVO Marks a Significant Achievement in Healthcare

ANEUVO, renowned for its groundbreaking work in non-invasive therapies, is on the brink of expanding its reach by hitting two critical milestones. The company has successfully achieved ISO 13485 compliance and secured CE Mark certification for its pioneering device, the ExaStim Stimulation System. These achievements reinforce ANEUVO's unwavering commitment to safety and quality, opening doors for the ExaStim device in the European healthcare market.

Understanding the CE Mark Certification

The CE Mark is essential as it certifies that the ExaStim device meets the European Union's rigorous health and safety standards established under the Medical Devices Regulation. This certification enables ANEUVO to market and sell ExaStim across Europe, thus giving clinicians and patients access to a revolutionary, non-invasive therapy specifically designed for enhancing motor function in those suffering from chronic spinal cord injuries (SCI).

The Importance of Non-Invasiveness

The non-invasive nature of the ExaStim device is a game changer. It offers a safe alternative to traditional treatments that may require surgical intervention. By delivering spinal cord stimulation without the need for incisions, ExaStim presents a new horizon for treatment options aiming to restore functionality in patients who have endured the challenges of spinal injuries.

ANEUVO's Vision for the Future

Dr. Yi-Kai Lo, co-founder and CEO of ANEUVO, highlights the significance of receiving the CE Mark. He describes it as a transformative moment for the company and emphasizes its potential to provide crucial therapies for those in need. This accomplishment not only signifies regulatory approval but also represents a leap towards real-world clinical applications that can change lives.

ISO 13485 Compliance: A Mark of Quality

Achieving ISO 13485 compliance is no small feat. This internationally recognized standard for quality management in medical devices reflects ANEUVO's dedication to global safety and reliability. It ensures that the company adheres to the highest quality control measures, which is essential in the highly regulated medical field.

Expanding Horizons in the European Market

The introduction of the ExaStim device in Europe is a vital step in ANEUVO's plan for global expansion. As Europe is known for its leadership in medical innovation, launching ExaStim here could significantly impact the treatment landscape for patients suffering from chronic conditions. With these certifications firmly in place, ANEUVO is poised to scale operations and deliver transformative technologies worldwide.

Inside the ExaStim Stimulation System

The ExaStim Stimulation System represents an innovative advance in bioelectronic medicine. It uses targeted and selective spinal cord stimulation to restore vital connections within the nervous system. This portable neurostimulation device operates through multi-electrode pads that deliver electrical pulses directly to affected nerves. The convenience of controlling this system via standard mobile devices adds to its appeal, making it accessible and user-friendly.

About ANEUVO: Pioneering Bioelectronic Medicine

ANEUVO is at the forefront of developing bioelectronic solutions aimed at enhancing the quality of life for individuals facing disabling diseases. With its cutting-edge biotechnology platform, ANEUVO is dedicated to overcoming significant healthcare challenges, striving to deliver effective solutions to underserved patients globally. The company's mission reflects a commitment to creating a healthier and more equitable world.

Contact Information

For U.S. Media Inquiries:

Diane Mulligan

President

M&C Communications

Email: dmulligan@mandccommunications.com

Phone: +1 720 273-0927

For EU Media Inquiries:

Akampion

Dr. Ludger Wess / Ines-Regina Buth

Email: info@akampion.com

Phone: +49 40 88 16 59 64 / +49 30 23 63 27 68

Frequently Asked Questions

What is the ExaStim Stimulation System?

The ExaStim Stimulation System is a portable neurostimulation device that non-invasively delivers spinal cord stimulation to aid recovery from chronic spinal cord injuries.

What does the CE Mark certification signify?

The CE Mark certification indicates that the ExaStim device complies with European health and safety regulations, allowing it to be marketed in Europe.

How does the ExaStim device work?

ExaStim uses electrical pulses delivered through a multi-electrode pad to stimulate spinal cord nerves, enhancing motor function in patients.

What is ISO 13485 compliance?

ISO 13485 compliance certifies that ANEUVO follows stringent quality management standards essential for medical devices, ensuring safety and reliability.

What are ANEUVO's future plans?

ANEUVO aims to expand its reach by introducing ExaStim to key markets, enhancing treatment options for individuals with chronic conditions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 144

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 112

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 294

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 507

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 57

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 169

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 116

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 74

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Emerie.ai: Transforming Customer Experience in FinTech

Updated Category News Views 489

Introducing Emerie.ai Emerie.ai, formerly known as ENACOMM Financial Services, Inc., represents a significant step forward in the FinTech arena. The company has undergone a rebranding to better reflect its core offering—an Intelligent Virtual Assistant (IVA)—which utilizes cutting-edge artificial intelligence technology. As customer service standards continue to rise,...

Continue Reading
Explore the Groundbreaking JumpCloudLand Conference 2026

Updated Category News Views 183

JumpCloudLand Conference: A New Era for IT Professionals JumpCloud Inc. has launched a remarkable initiative—JumpCloudLand, a comprehensive virtual conference tailored for IT professionals. This dynamic event is set to take place on February 10, 2026, providing a unique opportunity for IT leaders globally to gather and enhance their skills. The nature of IT is...

Continue Reading
General Shale Introduces an Innovative Brick Collection for 2026

Updated Category News Views 220

Innovative Brick Collection from General Shale for 2026 Transforming Spaces with Stylish Brick Designs For years, clay brick has symbolized durability and tradition. General Shale is now revolutionizing brickwork by introducing a new collection that transforms brick into a modern art form, showcasing a range of sizes, textures, and colors. Their contemporary lineup...

Continue Reading
Revolutionary Breakthrough in Gene Therapy for SCN2A Disorders

Updated Category News Views 269

Groundbreaking Research at UCSF Offers New Hope The laboratories led by Dr. Kevin Bender and Dr. Nadav Ahituv have made significant strides in gene therapy through groundbreaking research. Their recent study unveils a compelling new approach to address SCN2A haploinsufficiency, a critical factor linked to various neurodevelopmental disorders and early-onset epilepsy. This...

Continue Reading
FirstEnergy's New Leadership: Brian Tierney Takes Charge

Updated Category News Views 476

FirstEnergy Corporation Welcomes Brian Tierney as Chair FirstEnergy Corp. (NYSE: FE) has announced the appointment of its President and Chief Executive Officer, Brian X. Tierney, as the new Chair of the Board. This change takes effect on a future date, bringing fresh leadership to the company valued at $22.6 billion. Tierney, who has been in the role of President and CEO...

Continue Reading